UPDATE: Incyte (INCY) Tops Q3 EPS by 12c, Beats on Revenues; Boosts FY17 Jakafi Net Product Revenue Guidance
Go back to UPDATE: Incyte (INCY) Tops Q3 EPS by 12c, Beats on Revenues; Boosts FY17 Jakafi Net Product Revenue Guidance| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 104.13 +0.47 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.66 | 52 Week High | $118.49 | |||
| Open | $104.61 | 52 Week Low | $55.00 | |||
| Day High | $105.02 | P/E | N/A | |||
| Day Low | $103.07 | EPS | $-0.56 | |||
| Volume | 179,399 | |||||
